Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion type Assertion NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_head.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion evidence source_evidence_literature NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion SIO_000772 8558940 NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion wasDerivedFrom befree-20140225 NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.
- NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion wasGeneratedBy ECO_0000203 NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.